Savient Pharmaceuticals notches appellate court victory

Savient Pharmaceuticals, a specialty drugmaker that is developing a treatment for gout, said Thursday a federal appeals court had upheld the dismissal of a civil fraud suit brought by a group of shareholders. The litigation, citing financial restatements the East…

Excerpted from:
Savient Pharmaceuticals notches appellate court victory